Split-liver transplantation has been perceived as an important strategy to increase the supply of liver grafts by creating 2 transplants from 1 allograft. The Eurotransplant Liver Allocation System (ELAS) envisages that the extended right lobes (ERLs) after splitting (usually in the pediatric center) are almost exclusively shipped to a second center. Whether the ELAS policy impacts the graft and patient survival of extended right lobe transplantation (ERLT) in comparison to whole liver transplantation (WLT) recipients remains unclear. Data on all liver transplantations performed between 2007 and 2013 were retrieved from the Eurotransplant Liver Follow-up Registry (n 5 5351). Of these, 5013 (269 ERL, 4744 whole liver) could be included. The impact of the transplant type on patient and graft survival was evaluated using univariate and multivariate proportional hazard models adjusting for demographics of donors and recipients. Cold ischemia times were significantly prolonged for ERLTs (P < 0.001). Patient survival was not different between ERLT and WLT. In the univariate analysis, ERLT had a significantly higher risk for retransplantation (P 5 0.02). For WLT, the risk for death gradually and significantly increased with laboratory Model for End-Stage Liver Disease (MELD) scores of >20. For ERLT, this effect was seen already with laboratory MELD scores of >14. These results mandate a discussion on how to refine the splitting policy to avoid excess retransplant rates in ERL recipients and to further improve transplant outcomes of these otherwise optimal donor organs.
Split-liver transplantation (SLT) allows 2 recipients, in current practice usually an adult and a child, to benefit from 1 deceased donor liver. The United Network for Organ Sharing registry data and a few other institutional series demonstrated patient and graft survival outcomes similar to whole liver transplantation (WLT). (1) (2) (3) (4) (5) (6) Wider practice of SLT is, however, curtailed by a presumed higher vascular and biliary complication rate. (7, 8) Strict donor selection criteria, an optimal donor/recipient match, technical expertise, and adequate logistics to keep cold ischemia time (CIT) short are key for the success of SLT.
Eurotransplant (ET) has adopted the 50/50 rule. This rule is intended to increase awareness for SLT in ET and to document a transplant center's intention to split at the time of a postmortem whole liver offer. Each liver from a postmortem donor who meets the conditions >50 kg body weight and <50 years of age is considered a potential split-liver (SL) donor. A transplant center accepting the initial Eurotransplant Liver Allocation System (ELAS) whole liver offer can decide to split the liver and is then defined as the splitting center. The patient-oriented allocation algorithm for the second split is as follows: first, to highurgency (HU) patients (pediatric and adult); then, nationally, suitable recipients selected by ELAS Split Liver match; then, internationally, suitable recipients selected by ELAS Split Liver match. The consequence of this policy is that partial grafts after splitting, usually the extended right lobe (ERL), are shipped to another transplant center thus prolonging CIT.
Other countries/regions follow a different policy, where both the left lateral lobe (LLL) and the ERL either stay in the same center or the transfer of the one part is kept as short as possible. (9) Organ Procurement and Transplantation Network (OPTN) data, for example, show that 68% of the splits stay "local," 29% stay "regional," and only 3% are distributed nationally. (10) This system ensures CITs that are only marginally longer than those for WLT (7.2 hours adult WLT versus 8 hours adult SLT). (10, 11) The ELAS system may furthermore have technical implications for the split that is given away: the inclination for a technical compromise during the split procedure may be different when both splits stay in 1 center.
Whether creating 2 split grafts from a standard criteria whole liver would compromise outcomes in adult recipients within the ET framework remains unclear. In this study, we have analyzed the ET liver follow-up data to compare survival outcomes and retransplantation rates between extended right lobe transplantation (ERLT) and WLT in adult recipients.
Patients and Methods
The project was approved by the Eurotransplant Liver and Intestine Advisory Committee (ELIAC). Data of all liver transplantations (LTs) from donation after brain death (DBD) performed in the ET area from 2007 to 2013 were extracted from the LT follow-up registry. The study population is detailed in Fig. 1 .
The following information was used for further statistical evaluation: technique of the transplant (WLT versus ERLT), date of the transplant, sex of the donor/recipient, age of the donor/recipient, date of death, date of retransplantation, date of the last visit, laboratory MELD score of the recipient at the time of transplantation, and underlying condition for the liver failure. Specifically, for the donors, height, weight, and cause of death were analyzed.
Only 30% of the patients had a record on CIT, whereas the data on combined cold and warm ischemia times (WITs) were recorded in 99.5%. Therefore, only the data on the combined cold and warm ischemia times were used for multivariate analyses.
STATISTICS
Patient and graft survival were estimated by using Kaplan-Meier curves. Graft survival was a combined endpoint, defined as the time from diagnosis to either the patient's death or retransplantation, whatever comes first. For the analyses of time to retransplantation, cumulative incidences were estimated considering death without retransplantation a competing event. (12) Multivariate analyses were performed using proportional hazards models. For the time to retransplantation, these have to be interpreted as cause-specific hazard models. In all analyses, patients who did not experience an event were censored at the date of last observation. Model selection was done using the likelihood ratio test.
Comparisons of continuous variables (eg, age) were done with the t test, and comparisons of categorial variables were done with the chi-square test. P values <0.05 were considered significant. All analyses were performed with the software R, version 3.2.5 (R Foundation for Statistical Computing, Vienna, Austria).
For the matched pairs analysis, all 269 ERLTs were compared with 269 WLTs, which were matched for donor age, recipient age, and laboratory MELD score. Patients were matched exactly for the laboratory MELD score, resulting in a median of 15 in both groups. For donor and recipient age, the difference between the matching partners had to be no more than 10 years. The R package "matching" was used.
Results

DEMOGRAPHICS
Altogether 5351 LTs (275 split, 5076 whole) were recorded by ET from 2007 to 2013. Of these, 5013 (269 split, 4744 whole) could be included (Table 1) . DCD livers were excluded. For 338 patients, information was inconsistent or essential information was missing. The median observation period was 3.31 years. In this data set, 1381 patients (28%) were recorded as "dead," and 3632 (72%) were recorded as "still alive." Overall, 521 (10%) retransplantations were recorded. Of these, 39 (14.4%) were retransplanted following ERLT and 482 (10.2%) following WLT. Donors were slightly more often males (56.2%) than females (43.8%). This was different when looking separately at the grafts for ERLT. Here, most of the grafts were from female donors ( Table 1 ; P 5 0.007). The laboratory MELD score was similar between ERLT and WLT recipients (19.9 6 11.7 versus 19.3 6 11.1; P 5 0.39). Donors (31.9 6 14.4 versus 43.3 6 14.7 years; P < 0.001) and recipients (44.3 6 18.2 versus 50.7 6 14.7 years; P < 0.001) of ERLs were significantly younger compared with those of the whole livers. Donors of the ERLs weighed significantly less (66.8 6 16.9 kg versus 77.2 6 19.2 kg; P < 0.001) and died more often from head trauma (8.6% versus 5.4%, P 5 0.04). Importantly, the ischemia times were significantly longer for ERLT compared with WLT (CIT, 12.1 6 3.3 hours versus 8.3 6 2.8; P < 0.001; combined CIT and WIT, 12.7 6 4.8 hours versus 8.8 6 4.3 hours; P < 0.001). Fig. 2A) . When using the laboratory MELD score as a continuous covariate in a proportional hazards model, ie, assuming a linear effect, we received a HR of 1.024 (95% CI, 1.019-1.028) per point (P < 0.001). Donor and recipient age also significantly contributed to the risk of death (HR, 1.012 and 1.023, respectively; each P < 0.001). Lastly, CIT and the combined CIT and WIT showed a significant negative impact on the survival (CIT-HR, 1.080; P < 0.001; combined CIT and WIT-HR, 1.015; P 5 0.01).
SURVIVAL
Multivariate analysis largely confirmed these results (Table 2 ). There was no change for patient survival after ERLT compared with WLT (P 5 0.41). Recipients with a laboratory MELD score of 20 had a significantly better survival than those with a score of >20 (P 5 0.001). With every point increase of the laboratory MELD score over 20, the survival deteriorated significantly (P < 0.001). Also, an every year increase of the donor and the recipient age had a significant negative impact (P < 0.001). Every hour increase of the combined CIT and WIT resulted in a significantly reduced patient survival (P 5 0.049). No such effect was seen for the sex of the donor (P 5 0.93).
In an additional model, we included an interaction between the type of transplantation technique and the laboratory MELD score. Here, the risk for death already started to increase with a laboratory MELD score of 14 for the ERLTs compared with 20 following WLT (Fig. 3) . Furthermore, the increase of the HR for death in relation to the laboratory MELD score is steeper after ERLT compared with WLT (Fig. 3) .
RETRANSPLANTATION
Using the Kaplan-Meier method, the actual 1-year, 3-year, and 5-year transplant survival rates were 75.6% (95% CI, 74.4%-76.9%), 68.5% (95% CI, 67.1%-69.9%), and 62.8% (95% CI, 61.2%-64.5%) following WLT and 68.0% (95% CI, 63.5%-74.8%), 66.9% (95% CI, 60.3%-72.1%), and 62.7% (95% CI, 56.5%-69.5%) for the ERLT, respectively. The Kaplan-Meier curves confirmed a slightly worse graft survival for the ERLT especially early after the transplant (Fig. 2B) . The curves assimilate thereafter indicating that ERLT may have potential benefits once they have overcome the early posttransplant period. Both curves unite at approximately 4 years after transplantation and follow a similar course thereafter.
When analyzing retransplantation and death without retransplantation separately, univariate analysis showed a 30% decreased risk for retransplantation following WLT compared with ERLT (HR, 0.68; P 5 0.02; Table 3 ). Donor and recipient age had a significant impact (HR per year, 1.007, P 5 0.02 per year increase of the donor; HR per year: 0.993, P 5 0.01 per year increase of the recipient). This indicates that the risk for retransplantation was higher the older the donor and the younger the recipient was. Increase of the combined CIT and WIT was identified as an independent risk factor for retransplantation with a HR per year of 1.032 (P < 0.001). Multivariate analysis drew a similar picture ( Table 3 ). The cause-specific HR for retransplantation was decreased roughly 30% for WLT versus ERLT (HR, 0.723; P 5 0.06; Table 3 ). We did not find any significant impact of the laboratory MELD score on the cause-specific hazard of retransplantation, regardless of the form of the effect assumed. Every year increase in age of the donor significantly increased the risk for retransplantation (P < 0.001), while every year increase in age of the recipient significantly decreased the risk for retransplantation (P < 0.001). Sex of the donor had no impact. Lastly, every hour increase of the combined CIT and WIT had a significant impact on the risk for retransplantation (P < 0.001).
MATCHED PAIR ANALYSIS
Matched pair analysis was performed as a sensitivity to test for the differences between ERLT and WLT. Patients were matched exactly for the laboratory MELD score, resulting in a median of 15 in both groups. For donor and recipient age, the difference between the matching partners had to be no more than 10 years assuming a negligible impact on the outcome. Median donor age was 31 years, whereas median recipient age was 50 years in both groups.
The median combined CIT and WIT for ERLT was 12.5 hours compared with 8.8 hours for WLT confirming the results shown before. As expected, the outcome with respect to survival and re-LT was similar compared with our previous analyses (Figs. 4A,B) . Univariate cause-specific hazards model for retransplantation revealed a HR of 0.632 (95% CI, 0.384-1.038; P 5 0.07). The corresponding analysis on patient survival again showed no impact of the transplant type (HR, 0.865; 95% CI, 0.616-1.213; P 5 0.40).
The disadvantage of the ERLT was a higher cumulative incidence of retransplantations, while the cumulative incidence of death was comparable. This analysis was not adjusted for the differences in the combined CIT and WIT and therefore reflects a more practical perspective than the multivariate analyses described above.
Discussion
Organ shortage affects many countries with severe consequences for the patients. OPTN data indicate that 20% of the patients with a MELD score of 15 and a "nonfulminant" course either die or have to be removed from the waiting list for deteriorating clinical status. (13) Similar data were found for the ET population. Here, patients on the waiting list were found to be removed for death or deteriorating clinical state in up to 30%. (14) For ET in particular, this situation has the potential to further deteriorate. From 2011 to 2016, a steady decline by 7% of deceased donors used for transplantation was recorded. (15) Although sociopolitical countermeasures have yet to show a positive effect, other options will have to be further explored. Use of non-heart-beating donation, for example, has doubled from 2010. Considering the liver, there are the following possibilities other than transplantation of the full organ:
Living donor liver transplantation (LDLT). 2. Deceased donor SLT.
In a region where deceased donor transplantation is fully established, the potential problems following LDLT weigh heavy. Vascular and biliary complications in the recipient are common (30%), and donor problems remain significant (20%-30%) ranging from minor problems to "aborted hepatectomies" (1.2%), "near miss" events (1.1%) to a donor mortality of 0.2%. (16, 17) The idea that "splits" of the liver could be transplanted was first realized in children receiving the LLL. (18, 19) The euphoria was dampened by the first results. (20) In a series of 30 SLTs, the survival for children was 67% and 20% for adults. Continuous efforts, however, resulted in substantial improvements. (2, 3) It was not long before a series of single-center reports could show similar survival rates compared with WLT.
(1,4,5) However, SLT remains a highly complex technique requiring considerable experience. Therefore, it was not surprising that broader-scale data did not reach the good quality that some single centers could achieve. (21) In an early analysis on 387 deceased SLT performed in US centers, graft and patient outcomes of ERLT (n 5 152) were comparable with WLT from "marginal donors" (donors > 60 years) and significantly worse compared with donors 18-40 years old. In other words, a significantly worse outcome had to be expected for ERL splits compared with WL grafts of comparable quality. Another analysis found that the retransplant rate was doubled after SLT. (22) An OPTN-based analysis compared first-time adult/child split recipients (568 adults, 508 children from 1996 to 2006) with 40,304 patients receiving whole liver transplantations. The main results were:
1. No difference in graft survival between ERLT and WLT when not adjusted.
Significantly worse graft survival for ERLTs versus
WLTs when adjusted. (11) A subgroup of very young donors (<18 years) showed an equal graft survival. With increasing age of the donors, the results for the right-side grafts (RSGs) became worse. 3. CIT is an independent risk factor for graft survival.
Though not specifically shown for the ERLs, the risk to lose the left split graft following pediatric LT was tripled when CIT was >12 hours compared with <6 hours. Notably, CITs were fairly similar between ERLT and WLT (8.7 versus 8.2 hours) corresponding well with most of the other reports on SLT which show CITs between 8 and 10 hours. (4, 5, 9, 11) A more recent analysis on 889 SLTs reported similar data. (10) Here, the authors concluded that SLT and WLT have similar outcomes when "high-risk" recipients are excluded for SLT.
Despite the increasing demand of organs and the improving results, SLT remains an infrequently performed procedure in the Western world. In the ET area, the percentage of postmortem SLT remains fairly constant at 5%. The latest OPTN/Scientific Registry of Transplant Recipients (SRTR) report revealed a similar rate. (23) The current ET policy regarding SL allocation is that the whole liver is shipped to the "splitting center" in which most of the times the left lateral segment is kept for a transplant of a child. From the "splitting center," the ERLs are transported to the center of the next patient on the waiting list. There are certain differences regarding the allocation process for German and "non"-German centers. However, national and international trafficking of the ERLs is common practice.
The logic behind the ET policy of a patientoriented allocation of the ERL within a nationwide allocation system is to avoid prioritization of adult patients in centers associated with a pediatric transplant program.
In situ splitting would most certainly help to reduce the ischemia times. (24) Also, it may help reduce some vascular and biliary complications as has recently been proposed. (25) However, there are also significant disadvantages that contribute to the current situation within ET where almost exclusively the ex situ preparation is performed-most importantly, the missing infrastructure of the donor hospitals and the complexity of the organization of the organ procurement to which several teams from different countries have to travel with tight schedules. However, also some technical issues favor the ex situ procedure, ie, the possibility for a complete inspection using angiography, cholangiography, or methylene blue instillation. A clear advantage of 1 technique over the other regarding graft or even patient survival has yet to be shown. (21, 25, 26) The aim of this article was to evaluate the outcome of ERLTs in comparison to WLTs in the ET area. For this, all LTs performed from 2007 to 2013 were included and analyzed. The significance of this report is that in ET CITs are far longer for the ERL compared with the WL grafts (50% increase for ERLT versus WLT). We therefore analyzed if this difference had a significant impact on graft and patient survival following ERLT. So far, there has been no comparable analysis.
Similar to other reports before, there was a significantly increased risk for retransplantation following ERLT. This, however, did not translate into a worse patient survival of the ERL recipients. Even though the laboratory MELD was not significantly different (19.9 ERLT versus 19.3 WLT), ERL recipients were younger by an average of 6 years. Furthermore, ERLs were from younger and presumably healthier donors indicating that these organs were of better quality compared with the WLs. The combined CIT and WIT was an independent risk factor for the graft and patient survival.
Shipping of the graft to an external center increases CIT. Moreover, the "give away" of the right lobe may result in a situation where the ERL is handled differently compared with when it stayed in the same center.
Finally, a good ERL/recipient match may be crucial for the success of SLT. (25) Accordingly, our data suggest that ERLT in patients with low laboratory MELD may achieve outcomes similar to WLT. With increasing laboratory MELD score, however, ERLT may be less tolerable.
Would anybody prefer SLT over WLT if there were enough organs? Certainly not! However, in times when every day many patients die on the waiting list or have to be removed for their clinical status, SLT is a valuable option. Trying to translate the actual benefit of SLT in numbers, an early SRTR-based analysis showed an increase of 11 years extra life per 100 livers compared with WLT and an additional 59 patients who could be transplanted. (22) This analysis of the ET follow-up data registry shares the limitations inherent with all registry analyses, including partially incomplete data sets and loss of follow-up. Allocation data in general cannot be extrapolated without caution because they are fundamentally related to the specifics of the allocation system used.
In conclusion, this analysis shows ET's experience with ERLT compared with WLT. Most importantly, the patient survival was not different although the rate of retransplantation was increased following ERLT. The inferior graft outcome within the ET allocation regimen can be in part attributed to significantly longer ischemia times for the ERLs. The best outcome for ERLT can be achieved when CITs are kept low and recipients with high laboratory MELD scores are avoided.
